These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23156880)

  • 41. Antiplatelet treatment in the secondary prevention of coronary and cerebrovascular disease: is there any place for novel agents?
    Ntalas IV; Milionis HJ; Kei AA; Kalantzi KI; Goudevenos JA
    Angiology; 2014 Jul; 65(6):473-90. PubMed ID: 23966569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dual antiplatelet therapy with clopidogrel and aspirin for secondary stroke prevention.
    Wang Y; Chen W; Wang Y
    Curr Cardiol Rep; 2015 Oct; 17(10):89. PubMed ID: 26294261
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Secondary prevention of stroke in Saskatchewan, Canada: hypertension control.
    Bartsch JA; Teare GF; Neufeld A; Hudema N; Muhajarine N
    Int J Stroke; 2013 Oct; 8 Suppl A100():32-8. PubMed ID: 23088414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Secondary prevention after ischemic stroke or transient ischemic attack.
    Bangalore S; Schwamm L; Smith EE; Singh IM; Liang L; Fonarow GC; Bhatt DL;
    Am J Med; 2014 Aug; 127(8):728-38. PubMed ID: 24681258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation on the compliance with secondary prevention and influence factors of ischemic stroke in Hainan province, China.
    Su Q; Yuan K; Long F; Wan Z; Li C; Cai Y; Zeng C; Wu Y; Wu H; Liu S; Li P; Zhou J; Chen C; Wang D; Yan L; Zhang Y; Dai M
    Vascular; 2014 Jun; 22(3):181-7. PubMed ID: 23929417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in the knowledge and compliance with secondary prevention of stroke between transient ischaemic attack patients with and without subsequent stroke.
    Zhao J; Zhou M; Guo J; Zhang J; Yang Y; Yu F; He L
    J Clin Nurs; 2014 Oct; 23(19-20):2939-48. PubMed ID: 24444395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transient ischaemic attacks - assessment and management.
    Leung ES; Hamilton-Bruce MA; Koblar SA
    Aust Fam Physician; 2010 Nov; 39(11):820-4. PubMed ID: 21301653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Secondary prevention after stroke/transient ischemic attack: A randomized audit and feedback trial.
    Geary L; Hasselström J; Carlsson AC; Eriksson I; von Euler M
    Acta Neurol Scand; 2019 Aug; 140(2):107-115. PubMed ID: 31017305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Should I start all my ischaemic stroke and TIA patients on a statin, an ACE inhibitor, a diuretic, and aspirin today?
    Sandercock PA
    J Neurol Neurosurg Psychiatry; 2003 Nov; 74(11):1461-4. PubMed ID: 14617697
    [No Abstract]   [Full Text] [Related]  

  • 50. A benefit-risk assessment of agents used in the secondary prevention of stroke.
    MacWalter RS; Shirley CP
    Drug Saf; 2002; 25(13):943-63. PubMed ID: 12381215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Transient ischemic attack, a medical emergency].
    Uchiyama S
    Brain Nerve; 2009 Sep; 61(9):1013-22. PubMed ID: 19803400
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medical therapy for secondary prevention of stroke.
    Regesta G
    Clin Exp Hypertens; 2002; 24(7-8):555-62. PubMed ID: 12450231
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.
    Zhang Q; Wang C; Zheng M; Li Y; Li J; Zhang L; Shang X; Yan C
    Cerebrovasc Dis; 2015; 39(1):13-22. PubMed ID: 25547900
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Secondary prevention of ischemic insult and transient cerebral ischemia. Is ASS alone enough?].
    Diener HC
    MMW Fortschr Med; 2003 May; 145 Suppl 2():111. PubMed ID: 14579505
    [No Abstract]   [Full Text] [Related]  

  • 55. Current guidelines on antiplatelet agents for secondary prevention of noncardiogenic stroke: an evidence-based review.
    Simmons BB; Yeo A; Fung K; ;
    Postgrad Med; 2010 Mar; 122(2):49-53. PubMed ID: 20203455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
    Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
    BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Partial peroxisome proliferator-activated receptor agonist angiotensin receptor blockers. Potential multipronged strategy in stroke prevention.
    Towfighi A; Ovbiagele B
    Cerebrovasc Dis; 2008; 26(2):106-12. PubMed ID: 18560212
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The management of cerebrovascular events].
    Sène Diouf F; Ndiaye MM
    Dakar Med; 2008; 53(1):7-19. PubMed ID: 19102112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advances in stroke: Prevention and health services delivery 2012-2013.
    Abbott AL; Goldstein LB
    Stroke; 2014 Feb; 45(2):371-2. PubMed ID: 24436236
    [No Abstract]   [Full Text] [Related]  

  • 60. [Antihypertensive treatment preceding cerebrovascular diseases is insufficient according to recommendations].
    Nielsen AA; Christensen C; Brandslund I; Eriksen EW; Schmitz A
    Ugeskr Laeger; 2008 Oct; 170(41):3246-50. PubMed ID: 18940158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.